Showing of 0 - 10 from 87 results
Dr reddy's - Total results - 87
Nov 07, 2016
Hillary win may pose pricing challenges for pharma cos: ReportA Democrat sweep in US polls may pose even greater pricing challenges for the pharma industry and pave the way for tighter pricing regulations for both brand name and generic drugs, according to a report.
Oct 10, 2016
Dr Reddy's launches generic Lamotrigine tablets in USThe company's product is generic version of GSK Group of companies' Lamictal tablets
Sep 16, 2016
Dr Reddy's inks pact with US-based Amgen to market three drugs in IndiaUnder the terms of collaboration, DRL will commercialise Xgeva (denosumab), Vectibix (panitumumab) and Prolia (denosumab) in India
Jul 07, 2016
Lupin, Dr Reddy's recall 1.7 lakh blood pressure, acidity tablets in USLupin Pharmaceuticals Inc -- is recalling 59,520 bottles of Lisinopril & Hydrochlorothiazid tablets USP 20mg/12.5mg, 5,880 bottles of Lisinopril tablets
May 29, 2016
Sun Pharma gets US subpoena over generic drugs pricingThe U.S. Department of Justice (DoJ) has subpoenaed India's largest drugmaker Sun Pharmaceutical Industries Ltd seeking information about the pricing and marketing of the generic drugs it sells in the United States, the company said on Saturday. The DoJ's antitrust division has also asked Sun Pharma's U.S
Feb 01, 2016
Now, IPCA Labs gets warning letter from USFDA for manufacturing lapses at 3 plantsThe plants have already been banned from supplying to the United States after the FDA inspected them in July 2014, January 2015 and March 2015
Dec 31, 2015
Warning letters for pharma cos galore: Now Cadila Healthcare faces USFDA heat, stock tanks 16%The Ahmedabad-headquartered company received a warning letter for its Moraiya formulation facility and Ahmedabad API facility
Dec 09, 2015
Sensex ends 274 pts lower, tanks over 1,100 pts in 6 sessions as parliament logjam, commodity slide weighMarket breadth fared badly as gainers outpaced losers by more than 3:1 with 2,215 stocks declining against 542 advances on BSE.
Dec 09, 2015
Dr Reddy's issues clarification to USFDA's warning letter for its two unitsLast month, the company had received a warning letter from the USFDA relating to two of its API manufacturing plants and a formulation plant in Andhra Pradesh and Telangana
Nov 26, 2015
Dr Reddy's gets a breather after USFDA gives more time to respond to warning letterThe country's second-largest drug maker last week said it received a warning letter from the US drug regulator relating to two of its API manufacturing plants and a formulation plant located in Andhra Pradesh and Telangana.